ArticleProstate international2024

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study.

Naoki Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.